Fig. 3
From: Predictive value of CCL2 in the prognosis and immunotherapy response of glioblastoma multiforme
CCL2 is an independent prognostic factor for the overall survival of GBM. A Distribution of the risk score in the TCGA training set. B The survival time and survival status between high- and low-risk groups. C Heatmap of the expression profiles of CCL2 in low- and high-risk groups. The dotted line indicated the median risk score and divided the cohort into low- and high-risk group. D Kaplan-Meier survival analysis of the overall survival (OS) of GBM patients in the high- and low-risk groups. E Time-dependent ROC analysis of the predictive efficiency of CCL2 on the 1-, 3-, and 5-years OS rate. F, G Univariate (F) and multivariate (G) cox analyses evaluating the independent prognostic value of CCL2 in OS of GBM patients